UTI Healthcare Fund - Dividend - Regular Plan

  • Previous Nav

  • Net Change on 03-07-2020

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Dividend | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
UTI Healthcare Fund - Regular Plan - Income Option 1.33 28.32 32.06 7.55 2.17 13.42
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care 3.20 31.86 26.34 4.73 -0.39 13.92
S&P BSE Health Care - TRI 3.23 31.90 27.74 5.52 0.28 12.94

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
UTI Healthcare Fund - Regular Plan - Income Option Aug 25, 1999 32.06 7.55 2.17 2.53 474.52
Nippon India Pharma Fund-Dividend-Dividend Jun 05, 2004 32.75 13.01 6.68 2.24 2,991.57
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN - DIVIDEND Jul 03, 1999 32.96 4.83 0.54 2.33 1,138.75

Fund Holdings as on 31-May-2020

  • EQ DR REDDY'S LABORATORIES LTD.

  • EQ CIPLA LTD.

  • EQ AUROBINDO PHARMA LTD.

  • EQ SUN PHARMACEUTICALS INDUSTRIES LTD.

  • EQ LUPIN LTD.

  • EQ DIVIS LABORATORIES LTD.

  • EQ BIOCON LTD.

  • EQ CADILA HEALTHCARE LTD.

  • EQ IPCA LABORATORIES LTD.

  • EQ AJANTA PHARMA LIMITED

  • EQ ERIS LIFESCIENCES LTD

  • EQ LAURUS LABS LTD.

  • EQ SYNGENE INTERNATIONAL LTD.

  • EQ FDC LIMITED

  • EQ TORRENT PHARMACEUTICALS LTD.

  • EQ NARAYANA HRUDAYALAYA LTD

  • EQ NATCO PHARMA LTD.

  • EQ ABBOTT INDIA LTD.

  • EQ APOLLO HOSPITALS ENTERPRISE LTD.

  • EQ SANOFI INDIA LTD.

  • EQ DR. LAL PATHLABS LTD.

  • NET CURRENT ASSETS

  • EQ ADVANCED ENZYME TECHNOLOGIES LTD

  • EQ METROPOLIS HEALTHCARE LTD

  • EQ ALKEM LABORATORIES LTD

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

View More

Fund Manager

Most Recent Dividend

  • 29/10/2010

  • 27/08/2008

  • 12/01/2006

  • 11/11/2004

  • 24/11/2003

  • Cash

  • Equity

View More

About UTI Healthcare Fund

Scheme Analysis

UTI Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to UTI Mutual Fund. It was launched on 25-Aug-1999 and currently has an AUM of ₹474.52 crore. UTI Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of UTI Healthcare Fund ended up ₹0.41(0.51%)yesterday to ₹81.1878.

Among its top 3 holdings the fund has exposure to EQ DR REDDY'S LABORATORIES LTD., and

The UTI Healthcare Fund is managed by V. Srivatsa .

Fund House Contact

UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 66786666
service@uti.co.in
+91 (22) 66786503,56786578
www.utimf.com